87 FR 53 pgs. 15431-15432 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel; (SEP)—CE22-006, “Research Grants To Evaluate the Effectiveness of Physical Therapy-Based Exercises and Movements Used To Reduce Older Adults Falls (U01)”; Amended Notice of Meeting
Type: NOTICEVolume: 87Number: 53Pages: 15431 - 15432
Pages: 15431, 15432FR document: [FR Doc. 2022-05748 Filed 3-17-22; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Centers for Disease Control and Prevention
Official PDF Version: PDF Version
[top]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special Emphasis Panel; (SEP)-CE22-006, "Research Grants To Evaluate the Effectiveness of Physical Therapy-Based Exercises and Movements Used To Reduce Older Adults Falls (U01)"; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel; (SEP)- CE22-006, "Research Grants To Evaluate the Effectiveness of Physical Therapy-Based Exercises and Movements Used To Reduce Older Adults Falls (U01)", May 17-18, 2022, 8:30 a.m., EDT-5:30 p.m., EDT, Web Conference, in the original FRN. The meeting was published in the Federal Register on January 14, 2022, Volume 87, Number 10, page/s/ 2438.
The meeting is being amended to change the meeting date and should read as follows: CE22-006, "Research Grants To Evaluate the Effectiveness of Physical Therapy-Based Exercises and Movements Used To Reduce Older Adults Falls (U01)", May 17, 2022, 8:30 a.m., EDT-5:30 p.m., EDT.
The meeting is closed to the public.
FOR FURTHER INFORMATION CONTACT:
[top] Aisha L. Wilkes, M.P.H., Scientific
The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-05748 Filed 3-17-22; 8:45 am]
BILLING CODE 4163-18-P